• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OBALON THERAPEUTICS, INC OBALON BALLOON SYSTEM; INTRAGASTRIC BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OBALON THERAPEUTICS, INC OBALON BALLOON SYSTEM; INTRAGASTRIC BALLOON Back to Search Results
Model Number PN7500
Device Problems Burst Container or Vessel (1074); Entrapment of Device (1212)
Patient Problem Foreign Body In Patient (2687)
Event Date 02/27/2017
Event Type  malfunction  
Event Description
On (b)(6), a female patient came for a second balloon placement procedure.The balloon capsule was swallowed and inflated uneventfully.However during the catheter retrieval process the catheter burst proximally from the patient's mouth, and distally from the catheter luer.This burst resulted in a breach in the closed loop gas pathway that leads to balloon depressurization leaving an underinflated balloon in the body.Representatives from obalon recommended that the balloon be removed endoscopically according to the labeling.The balloon was not removed.The breached catheter was returned to obalon for investigation.The catheter was sent for sem and the root cause of the burst was due to a bite impression located distally from the burst.The resulting investigation concluded that the balloon does not have sufficient pressurization and should be removed in order to maintain patient safety and prevent serious injury.Radiographs performed on (b)(6) showed that the balloon was still in the fundic region.To date, the balloon has not been removed and the manufacturer continues to recommend balloon removal.Per the labeling, an underinflated balloon can lead to a full balloon deflation resulting in an increased potential for migration/obstruction leading to serious injury.Labeling also indicates that the balloon pressure cannot be determined using radiography alone.Patients reporting a loss of fullness, increased hunger, and/or weight gain should be examined by radiograph, as this may be a sign of balloon deflation.Additionally, any increase in nausea, vomiting and/or cramping after initial symptoms have subsided may indicate a deflated balloon.Patients should be evaluated by radiograph and endoscopic visualization might be required if the state of inflation cannot be determined radiographically.In the event of balloon deflation, the balloon should be removed as soon as possible.
 
Manufacturer Narrative
This report is an update to the previous report that indicates that the patient has returned for an endoscopic removal.The procedure was successful without any clinical sequelae.Both balloons were still in the stomach, in the fundic region with no symptoms of migration or obstruction.The balloons were returned for further examination.The balloons were normal with the exception of the expected holes and grasper marks from the removal procedure.The suspect balloon from the adverse event report had notable crosshatch which is a precursor to premature fatigue due to the low inflation pressures of the balloon.The balloon did not otherwise have any breaches or leaks that would have caused deflation after being ejected from the catheter.
 
Event Description
On (b)(6) 2017, a female patient came for a second balloon placement procedure.The balloon capsule was swallowed and inflated uneventfully.However during the catheter retrieval process the catheter burst proximally from the patient's mouth, and distally from the catheter luer.This burst resulted in a breach in the closed loop gas pathway that leads to balloon depressurization leaving an underinflated balloon in the body.Representatives from obalon recommended that the balloon be removed endoscopically according to the labeling.The balloon was not removed.The breached catheter was returned to obalon for investigation.The catheter was sent for sem and the root cause of the burst was due to a bite impression located distally from the burst.The resulting investigation concluded that the balloon does not have sufficient pressurization and should be removed in order to maintain patient safety and prevent serious injury.Radiographs performed showed that the balloon was still in the fundic region.This report is an update to the previous report that indicates that the patient has returned for an endoscopic removal.The procedure was successful without any clinical sequelae.Both balloons were still in the stomach, in the fundic region with no symptoms of migration or obstruction.The balloons were returned for further examination.The balloons were normal with the exception of the expected holes and grasper marks from the removal procedure.The suspect balloon from the adverse event report had notable crosshatch which is a precursor to premature fatigue due to the low inflation pressures of the balloon.The balloon did not otherwise have any breaches or leaks that would have caused deflation after being ejected from the catheter.Per the labeling, an underinflated balloon can lead to a full balloon deflation resulting in an increased potential for migration/obstruction leading to serious injury.Labeling also indicates that the balloon pressure cannot be determined using radiography alone.Patients reporting a loss of fullness, increased hunger, and/or weight gain should be examined by radiograph, as this may be a sign of balloon deflation.Additionally, any increase in nausea, vomiting and/or cramping after initial symptoms have subsided may indicate a deflated balloon.Patients should be evaluated by radiograph and endoscopic visualization might be required if the state of inflation cannot be determined radiographically.In the event of balloon deflation, the balloon should be removed as soon as possible.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OBALON BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
OBALON THERAPEUTICS, INC
5421 avenida encinas
suite f
carlsbad CA 92008
Manufacturer (Section G)
OBALON THERAPEUTICS, INC.
5421 avendia encinas
suite f
carlsbad CA 92008
Manufacturer Contact
amy vandenberg
5421 avenida encinas
suite f
carlsbad, CA 92008
7607956558
MDR Report Key6408502
MDR Text Key70315853
Report Number3009256831-2017-00014
Device Sequence Number1
Product Code LTI
UDI-Device Identifier00859810006036
UDI-Public(01)00859810006036(17)171218(10)161219403
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Medical Equipment Company Technician/Representative
Remedial Action Other
Type of Report Initial,Followup
Report Date 04/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/15/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/18/2018
Device Model NumberPN7500
Device Lot Number161219403
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/04/2017
Is the Reporter a Health Professional? No
Date Manufacturer Received02/27/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/19/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-